Salute e Benessere

Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of…

Company announcement, Helsinki, 17 June 2024 at 12:45 PM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Leena Niemistö on 17 June 2024.The notification is based on the amendment to the Securities Market Act effective April 19, 2024, requiring shareholders to notify the...
Nasdaq GlobeNewswire
17/06/2024

Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for…

Professor Kouzarides has been dedicated to the conversion of science into patient benefit throughout his career. Professor Kouzarides has been dedicated to the conversion of science into patient benefit throughout his career. STORM Therapeutics was spun out from theUniversity of Cambridgein 2015 by Professor Kouzarides and his colleague ProfessorEric Miska, following their groundbreaking work in RNA epigenetics. Professor Kouzarides and his research group identified the importance of...
PR Newswire
17/06/2024

Funding secured for CE approval of the groundbreaking C-MIC device from Berlin…

To date, 35 C-MICs have been successfully implanted in a randomized study. The excellent data from a previous pilot study with 10 patients has now been confirmed. Accordingly, the company was able to raise a further CHF 10 million from new and existing investors in a recent financing round. This means that CE approval is financially secured and the next steps for US approval can be initiated. These funds will also be used to initiate the first studies in the USA. To date, 35 C-MICs have been...
PR Newswire
17/06/2024

Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in…

In the intention-to-treat population (118 participants), safety and tolerability were not significantly different between groups. In the secondary outcomes, MUNIX showed a significantly reduced decline with Fasudil 60 mg at 26 and 90 days, and for Fasudil 30 mg at 90 days after treatment initiation. In addition, there was a directional difference in a slower loss of SVC favoring the 60 mg of fasudil treatment at day 26, which was statistically significant in a post-hoc subgroup analysis of…
PR Newswire
17/06/2024

Essity decides to buy back shares for SEK 3bn

The share buyback program will be managed by Danske Bank, which will decide on the date for repurchasing independently from and outside of Essity's influence. Repurchasing will take place on Nasdaq Stockholm in accordance with the stock exchange's issuer regulations and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation). The share buyback program will be managed by Danske Bank, which...
PR Newswire
17/06/2024

Essity presents new financial targets

Annual organic sales growth >3% Essity's new target is annual organic sales growth of more than 3%. The previous target was an annual sales growth of more than 5%, which included organic sales growth of more than 3% and acquisitions of approximately 2%. Acquisitions remain part of the company's strategy but are no longer included in the annual growth target. Annual organic sales growth >3% Essity's new target is annual organic sales growth of more than 3%. The previous target was an...
PR Newswire
17/06/2024

XRP Healthcare Magazine Issue 3: Featuring Ugandan Innovator Peter Waiswa, NHS…

"I'm involved with XRP Healthcare because I admire their commitment to improving the quality and capacity of healthcare in Uganda. Currently, our healthcare system is fragmented, mostly privatised, and often lacks regulation. Despite this, we face complex health challenges. Investing in healthcare in Uganda and Africa holds great promise because the market is growing along with demand." "I'm involved with XRP Healthcare because I admire their commitment to improving the quality…
PR Newswire
17/06/2024

Casio to Release G-SHOCK with Workout Logs and More Comfortable Fit

The G-SHOCK first came out in 1983, delivering on a passion to create a tough watch that would not break even if dropped. Ever since, Casio has continued to introduce functional, structural, and design advancements to the brand's outstanding shock resistance. Stacked with data-tracking functions, the sports-driven G-SQUAD line in the G-SHOCK brand has proven very popular. The G-SHOCK first came out in 1983, delivering on a passion to create a tough watch that would not break even if dropped...
PR Newswire
17/06/2024

Roche's Phase III STARGLO study demonstrates Columvi significantly extends…

The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with Columvi plus chemotherapy 1 This Columvi combination could provide a much-needed off-the-shelf treatment option for people with transplant-ineligible R/R DLBCLData were featured in the congress Press Briefing and presented today in the Plenary Abstracts Session at EHA 2024 as a late-breaking...
Nasdaq GlobeNewswire
15/06/2024

Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in…

Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual European Hematology Association (EHA) 2024 Hybrid Congress. Galapagos' product candidate GLPG5101 is produced using the company's innovative, decentralized T-cell manufacturing platform.The oral...
Nasdaq GlobeNewswire
14/06/2024

Casino completes reverse share split Adjustments to the warrants exercise parity…

Casino completes reverse share splitAdjustments to the warrants exercise parity and allocation rights under free share allocation plans Paris, 14 June 2024Casino, Guichard-Perrachon (“ Casino ”) today announces (i) the completion of the reverse share split of its share capital through the exchange of one hundred (100) existing shares for one (1) new share and (ii) the effectiveness of the share capital reduction through a decrease in the par value of the shares decided by Casino's...
Nasdaq GlobeNewswire
14/06/2024

Medical Equipment Maintenance Market: Forecasted USD 88.9 Billion by 2029, CAGR…

Browse in-depth TOC on "Medical Equipment Maintenance Market" Browse in-depth TOC on "Medical Equipment Maintenance Market" 307 - Tables 58 - Figures 362 - Pages Industry Dynamics: Growth Drivers in Medical Equipment Maintenance Growth in Medical Equipment Markets:The global expansion of various medical equipment markets is fueled by the need for safer, more efficient, and higher-quality healthcare. Innovations in the sector further drive this growth, with patients...
PR Newswire
14/06/2024

Renovaro, Inc. Announces $10 million in Equity Committed

“We appreciate confidence in the Company demonstrated by the investors,” said the Hon. Mark Dybul, MD, CEO. “We believe this is only the beginning. We are hopeful to be able to secure additional financing such as, but not limited to, long-term loans, grants and subsidies from various US and European institutions for which the Company is eligible – potentially worth tens of millions of dollars.” Forward-Looking Statements Statements in this press release that are not strictly historical...
Nasdaq GlobeNewswire
14/06/2024

UN OFFICIALS VISIT HUMAN APPEAL PROJECT FOR 1500 FAMIILIES IN NORTHWEST SYRIA

So far 1,500 temporary dignified shelters have been constructed in Al Yasameen IDP site for Syrian families displaced by conflict. The project also recently installed a water well and a water tank in each shelter to support the families that will move in. The light-briquette dignified shelters are specifically designed for families and offer much better protection than typical tent shelters, especially during harsh winter and summer weather conditions. So far 1,500 temporary dignified…
PR Newswire
14/06/2024

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for…

A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients' blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment effectiveness. At the end of a treatment cycle, both the patient and the treating physician have a clear view of the...
Nasdaq GlobeNewswire
14/06/2024

IQ Medical Ventures rebrands as IQ Women's Health to pioneer innovations in…

IQ Women's Health is dedicated to fostering innovation and supporting the development of cutting-edge solutions in women's health. The organization caters to the needs of physicians, start-ups, and investors, providing the resources, network, and regulatory guidance necessary to succeed in advancing women's health outcomes worldwide. IQ Women's Health is dedicated to fostering innovation and supporting the development of cutting-edge solutions in women's health. The organization caters to the...
PR Newswire
14/06/2024

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical…

The VenusP-Valve PROTEUS STUDY, abbreviated from Evaluation of the PerfoRmance Of The VEnUsP-Valve System in Patients with Native Right Ventricular Outflow Tract (RVOT) Dysfunction, is a prospective multi-center non-randomized interventional study in patients with RVOT disorders comorbid with moderate or greater pulmonary regurgitation. With a target enrollment of 60 subjects, data from this trial will support VenusP-Valve's registration with the U.S. FDA and Japanese Pharmaceuticals and Medical…
PR Newswire
14/06/2024

RAMSAY SANTE :Cosem medical centers takeover

PRESS RELEASEParis, June 14 th2024 Ramsay Santé sustains the local healthcare offering, in sector 1, for more than one million patients, by taking over 11 Cosem multidisciplinary medical centres Ramsay Santé, the European leader in private hospitalization and primary care, announces the takeover of 11 Cosem medical centres.Ramsay Santé's offer covers the existing Cosem centres in Paris, Evry, Caen, Orléans, and Marseille, which care for over 1 million patients annually in...
Nasdaq GlobeNewswire
14/06/2024

Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee…

Key Findings from the Pilot Trial Based on the Interim Report with the first 10 Subjects at the 6-Month Follow-Up: Key Findings from the Pilot Trial Based on the Interim Report with the first 10 Subjects at the 6-Month Follow-Up: "Cartilage defects are prevalent, particularly among athletes, and existing treatments are often unreliable. The initial results with COPLA® are impressive, showing promise for active patients by enabling early weight-bearing, swift rehabilitation, and a quick...
PR Newswire
14/06/2024

Casino Group enters into exclusive negotiations with Auchan Retail France and…

Casino Group enters into exclusive negotiations with Auchan Retail France and Rocca with a view to selling its Corsican subsidiary Codim 2 Paris, 14 June 2024The Casino group announces that it has entered into exclusive negotiations with Auchan Retail France and Rocca with a view to selling its subsidiary Codim 2 which operates in Corsica 4 hypermarkets, 9 supermarkets, 3 cash & carries and 2 drive-throughs, having achieved a turnover excluding taxes of 332 million euros in 2023...
Nasdaq GlobeNewswire
14/06/2024

The Enterprise Court of Nivelles approves the BioSenic restructuring plan  

PRESS RELEASE – PRIVILEGED INFORMATIONMont-Saint-Guibert, Belgium, June 14, 2024 7.00am CEST –BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, as well as cell repair, announces that it has received the homologation judgment for the restructuring plan filed with the Enterprise Court of Nivelles. This homologation judgment makes the plan binding on all deferred creditors, and the measures provided...
Nasdaq GlobeNewswire
14/06/2024

Modern Meadow and Earthletica Announce World's First Sustainable Collaboration…

NUTLEY, N.J. and SYDNEY, June 13, 2024 /PRNewswire/ -- Modern Meadow, a creator of innovative, environmentally-friendly biomaterials whose mission is to enable the world to transition to sustainable materials, and Earthletica, an Australian-based company focused on sustainable and high-performance activewear, today announced their collaboration on the Bronte Jacket, named in recognition of competitive swimmer and dual Olympic gold medalist and world champion, Bronte Campbell OAM. This…
PR Newswire
14/06/2024

ONWARD® Medical Announces Results of Annual General Meeting of Shareholders

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutionsEINDHOVEN, the Netherlands, June13, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces all proposed...
Nasdaq GlobeNewswire
13/06/2024

Global Artificial Blood Vessels Market to Surpass 3 Billion Mark by 2030 |…

Key Takeaways from the Artificial Blood Vessels Market Report Key Takeaways from the Artificial Blood Vessels Market Report To read more about the latest highlights related to the artificial blood vessels market, get a snapshot of the key highlights entailed in theGlobal Artificial Blood Vessels Market Report Artificial Blood Vessels Overview Artificial blood vessels, often crafted from biocompatible materials like polymers or metals, represent a groundbreaking innovation in...
PR Newswire
13/06/2024
Altri  Comunicati